Vestibo

Vestibo - a drug used to treat diseases of the nervous system.

Release form and composition

Vestib is released in the form of white flat, round, with beveled edges of the tablets, on one side of which there is the marking "B8", in blisters of 10 pieces.

Each tablet contains 8 mg of betahistine dihydrochloride and excipients such as:

• 2 mg of povidone K90;
• 2.5 mg of colloidal silicon dioxide;
• 4.5 mg stearic acid;
• 6 mg of crospovidone;
• 33 mg microcrystalline cellulose;
• 70 mg of lactose monohydrate.

Also they produce round Vestibo tablets with bevelled edges, on one side of which there is an “B16” marking, in blisters of 10 pcs.

One tablet contains 16 mg of betahistine dihydrochloride and excipients - 66 mg of microcrystalline cellulose, 4 mg of povidone K90, 5 mg of colloidal silicon dioxide, 140 mg of lactose monohydrate, 9 mg of stearic acid and 12 mg of crospovidone.

Another form of release Vestibo are biconvex, with a risk on one side of the tablet, 10 pieces each. in blisters.

Each tablet contains 24 mg of betahistine dihydrochloride and excipients - 7.5 mg of colloidal silicon dioxide, 6 mg of povidone K90, 18 mg of crospovidone, 210 mg of lactose monohydrate, 99 mg of microcrystalline cellulose and 13.5 mg of stearic acid.

Indications for use

Vestibo is used in cases of vestibular neuritis, Meniere's disease, labyrinthitis, dropsy of the labyrinth of the inner ear, benign positional dizziness, atherosclerosis of cerebral vessels, post-traumatic encephalopathy and vertebrobasilar insufficiency.

Also, the drug is used to treat vestibular and labyrinth disorders.

Contraindications

Application Vesibo contraindicated in the first trimester of pregnancy, with bronchial asthma, pheochromocytoma, gastric ulcer and 12 duodenal ulcer in the acute phase, as well as in cases of hypersensitivity to the components that make up the drug.

With caution, the drug is prescribed to children in the second and third trimester of pregnancy, as well as in cases of gastric ulcer or duodenal ulcer in history.

Dosing and Administration

The drug is taken orally during a meal, washed down with a small amount of water. Dosage means 1-2 tablets (8 mg) 2-4 times a day. The duration of Vestibo treatment is determined by the doctor individually and depends on the body's response to treatment.

Side effects

The instructions to Vestibo stated that the tool can cause dyspepsia, skin rash, nausea, angioedema and vomiting.

Symptoms of an overdose of the drug are bronchospasm, headache, tachycardia, flushing of the skin, decrease in blood pressure and dizziness.

special instructions

It should be borne in mind that after the use of Vestibo in some cases, the expected therapeutic effect appears only after a few months from the start of treatment.

Analogs

Synonyms of the drug are such medicines as:

• Mikrozer;
• Betacentrin;
• Asniton;
• Tagista;
• Vestikap;
• Denoise;
• Vazoserc.

Analogs of Vestibo are the medicines Stugeron and Cinnarizine.

Terms and conditions of storage

Vestibo, according to the instructions, should be stored in a dry, well-ventilated, out of the reach of children and light place, at a temperature not exceeding 25 ° C.

The drug is released from pharmacies by prescription, the shelf life of tablets is three years. After the expiry date, the site must be disposed of.